Skip to main content
Premium Trial:

Request an Annual Quote

Cancer Dx Firm Pacific Edge Achieves CLIA Registration to Offer Bladder Cancer Test in US

NEW YORK (GenomeWeb News) – New Zealand cancer diagnostics company Pacific Edge said today its US Laboratory has achieved registration under the CLIA regulatory process, setting the stage for it to offer its bladder cancer test in the US.

CLIA registration means that Pacific Edge's laboratory in Hershey, Penn., will be able to operate and process urine samples from patients in the US for its laboratory-developed test called Cxbladder. The non-invasive, urine-based test uses molecular signatures to identify the presence of bladder cancer tumors.

In addition to the US, Cxbladder is available in Australia and New Zealand, and the firm anticipates making the test commercially available in Spain soon. Pacific Edge has licensing deals with Oryzon in Spain and Healthscope in Australia for the test.

According to Pacific Edge CEO Jackie Walker, CLIA registration marks the transition of the test to full commercialization mode. The firm has the core of its sales and marketing team in the US in place and is working with urologists on incorporating Cxbladder into their practices. During the coming months, additional sales and marketing personnel will be added, the company said.

Based in Dunedin, New Zealand, Pacific Edge develops diagnostic and prognostic technologies directed at cancer detection and monitoring.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.